Background/Aims: Atherosclerosis is a serious disease that increases the risk of myocardial infarction and ischemic stroke. Previous studies have demonstrated that microRNA (miR)-29c could play significant roles in atherosclerosis via regulating inflammatory processes. However, the relationship between miR-29c and carotid intima-media thickness (CIMT) remains unknown. This study investigated associations between miR-29c and atherosclerosis and tested whether plasma miR-29c levels could be used to detect atherosclerosis. Methods: Plasma miR-29c levels were estimated by quantitative real-time PCR, and CIMT was measured by carotid ultrasound. Associations between miR-29c and CIMT were assessed by Spearman's correlation coefficient and multiple linear regression analyses. Results: In total, 170 participants were divided into the study (CIMT ≥0.9 mm) and control (CIMT <0.9 mm) groups. The study group showed higher C-reactive protein (CRP) and miR-29c relative expression levels compared with the control group. CIMT was positively correlated with miR-29c (r=0.659, p<0.001) and CRP (r=0.447, p<0.001), and miR-29c levels were also correlated with CRP (r=0.512, p<0.001). Furthermore, multiple linear regression analysis showed that CIMT was significantly correlated with miR29c (β=0.573, 95% confidence interval [CI]: 0.315-0.839; p<0.001) and CRP (β=0.439, 95%CI: 0.186-0.825; p<0.001). After age, body mass index, systolic blood pressure, total cholesterol and fasting blood-glucose were adjusted for, CIMT was still closely associated with p<0.001) and CRP (β=0.417, p<0.001). Evaluating CRP and miR-29c together (AUC=0.900, p<0.001) achieved a better prognostic value for atherosclerosis than miR-29c (AUC=0.870, p<0.001) or CRP (AUC=0.722, p<0.001) alone. Conclusion: Increased miR-29c was closely associated with CIMT and may serve as a biomarker for identifying atherosclerotic patients.
Introduction
Atherosclerotic cardiovascular disease and its clinical complications, including myocardial infarction and ischemic stroke, are the primary causes of human morbidity and mortality worldwide [1] . At the same time, macro-vascular diseases, which include coronary heart disease, carotid artery disease, peripheral vascular disease, and cerebral vessel disease, involve damage to large arteries and lead to important reactions and manifestations of atherosclerotic cardiovascular disease, such as carotid artery [2] . It is widely accepted that increased carotid intima thickness (CIMT) is a symptom of atherosclerosis, and this is often considered the most obvious and important clinical marker of subclinical variation or macrovascular damage [3] . Additionally, measuring CIMT is routinely used to assess subclinical atherosclerosis or atherosclerosis [4] . CIMT has been shown to predict cardiovascular risk in multiple large cohort studies and can be used to recommend asymptomatic adults at intermediate risk of cardiovascular diseases for cardiovascular risk assessment [5, 6] . Atherosclerosis development is complicated, but one important hypothesis is that atherosclerosis is initiated by the vascular infiltration of several inflammatory cell types and/or inflammatory reactions [7] . C-reactive protein (CRP) was identified in 1930 to be an "acute phase protein" that is an early and important indicator of infectious or inflammatory conditions [8] . In most cases, CRP levels are closely related to atherosclerotic cardiovascular disease, and CRP is also as a vital marker of carotid atherosclerosis progression [9] .
Recently, a growing body of evidence has suggested that microRNAs (miRNAs) play vital roles in atherosclerosis development [10] . MiRNAs are a class of noncoding, single-stranded RNA molecules that are expressed in humans and involved in sequencespecific post-transcriptional regulation of gene expression [11] . MiRNAs have emerged as key players in a wide array of biological processes, and changes in their expression and/or function are associated with a plethora of human diseases [11, 12] . Studies have shown that microRNAs regulate several cellular and molecular processes associated with atherosclerosis development, ranging from risk factors, to plaque initiation and progression, up to atherosclerotic plaque rupture [11, 13] . Importantly, previous studies have revealed that miR-29c could play a multifaceted and important role in atherosclerosis formation [14] .
Although it has been suggested that miR-29c could play vital roles in atherosclerosis formation, there is no data regarding associations between CRP or CIMT and miR-29c, and there is also no data regarding the prognostic value of miR-29c for identifying patients at risk for developing atherosclerosis. Thus, this study was conducted to investigate whether miR29c levels differ between people with subclinical atherosclerosis to determine if circulating miR-29c could be a noninvasive marker for atherosclerosis in real-world population.
Materials and Methods

Study population
This was a cross-sectional study, and all participants are consecutively enrolled from the community, managed by Guangdong General Hospital (Guangdong, China). Patients with asymptomatic atherosclerosis were included, while patients with a history of coronary heart disease, cerebrovascular disease, diabetes mellitus, neck surgery, thyroid diseases, heavy smoking, cancer, carotid artery occlusion, acute infection disease, rheumatic immune disease, acute heart failure and relevant medications (lipid-lowering drugs, antiplatelet, or antihypertensive drugs, such as ACE/ARB, calcium channel/alpha/beta blockers or diuretic) were excluded. All participants underwent physical examinations and office blood pressure monitoring. Carotid arteries were examined using a standardized protocol. CIMT of the common carotid artery was measured using an ATL HDI 3000 ultrasound system (Advanced Technology Laboratories, Bothell, WA, USA) equipped with a 5 MHz linear array transducer as previously described [15, 16] [17] . The higher value between the left and right CIMT was used for analyses. A trained sonographer with registered diagnostic medical sonography certification performed all measurements. The glomerular filtration rate (GFR) was calculated by the Modification of Diet in Renal Disease Study Group [18] . This study was approved by the Medical Ethics Committee of Guangdong General Hospital, and written informed consent was obtained from each patient prior to participation. The study was conducted in accordance with the Declaration of Helsinki.
Sample collection
All samples were collected before treatment from patients and healthy volunteers in the morning after 12-14 h fasting. Plasma was extracted by centrifuging whole blood at 3, 000 rpm for 10 min at room temperature; plasma samples were collected and divided into two aliquots, which were then stored at -80°C for analysis. Fasting blood glucose, serum lipid, routine laboratory tests, and hepatic and renal functions were assayed using routine clinical laboratory methods.
MiR-29c detection
Total RNA containing small RNAs was extracted from plasma using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and purified with mirVana miR Isolation Kit (Ambion, Austin, TX, USA) according to the manufactures' protocols [19, 20] . We evaluated the expression of plasma miRNAs using the S-Poly (T) RT-qPCR method as previously described [21] , with miR-54 as an internal control [22] . Mean Ct values and deviations between duplicates were calculated for all samples using the following formula: ΔCt = Ct (miR) -Ct (miR-54). Primers used were 5′-uagcaccauuugaaaucgguua-3′for rmiR-29c. The relative miR expression level was determined using the formula 2−ΔΔCT.
Statistical analysis
We found a sample size of n=63 per group is required to provide 80% power to detect a difference in the mean relative expression levels with a significance of 0.05(2-sidedα). All continuous variables are expressed as mean ± standard deviation. Normal distribution was tested using the Kolmogorov-Smirnov test. The chisquare test or Fisher's exact test was used to compare categorical variables. The Mann-Whitney U test or Student's t-test were used for continuous variables between patients and controls. Correlations between continuous variables were assessed using Spearman's correlation coefficient. Multiple linear regression analysis was used to assess relationships between miR-29c levels and CIMT or CRP. Age, body mass index, systolic blood pressure, and fasting blood glucose were adjusted. Statistical significance was defined as twosided p < 0.05. The predictive value for diagnosing atherosclerosis was evaluated using receiver operating characteristic (ROC). Area under the ROC curve (AUC) was used as an accuracy index for evaluating the diagnostic performance of the selected clinical marker. ROC and regression analyses were performed using 21MedCalc software (version 10.4.7.0; MedCalc, Mariakerke, Belgium). All other statistical analyses were performed using SPSS software (version 17.0; SPSS Inc., Chicago, IL, USA) and GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA).
Results
Clinical characteristics, and plasma CRP and miR-29c levels
Baseline data for all patients are shown in Table 1 ; at baseline, we found that the age, sex, body mass index, fasting blood glucose, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglyceride, glomerular filtration rate, diastolic blood pressure, and heart rate were not statistically different between the groups, while CRP, systolic blood pressure, and miR-29c were significantly different; the study group showed higher CRP and miR-29c relative expression levels, compared with the control group (Fig. 1A and 1B) .
Associations between miR-29c and CRP with CIMT As is shown in Table 3) .
Predictive value of miR-29c and CRP for subclinical atherosclerosis
Next, we performed a ROC analysis to determine the predictive values of miR-29c and CRP for subclinical atherosclerosis. We found that the combination of miR-29c and CRP (AUC=0.900, 95% CI: 0.857-0.944; sensitivity=97.5%, specificity=68.8%; p<0.001) offered a better predictive value for subclinical atherosclerosis than either miR-29c (AUC=0.870, 95% CI: 0.818-0.922; sensitivity=96.3%, specificity=56.9%; p<0.001) or CRP (AUC=0.722, 95% CI: 0.650-0.793; sensitivity=88.8%, specificity=63.3%; p<0.001) alone. Thus, the diagnostic performance of miR-29c and CRP together was superior to miR-29c or CRP independently (Fig. 2) . 
Discussion
In this study, we found that plasma miR-29c and CRP levels were higher in the study group compared with controls. CIMT was positively correlated with miR-29c and CRP, and miR-29c levels were also correlated with CRP. Importantly, these correlations were independent of age, body mass index, systolic blood pressure, total cholesterol, and fasting blood glucose in multivariate analysis. To the best of our knowledge, this study is the first to indicate that plasma miR-29c could be an independent predictor of subclinical atherosclerosis. Furthermore, the combined AUC of miR-29c and CRP was a better indicator of preclinical atherosclerosis than the AUC of either miR-29c or CRP alone.
It is generally accepted that atherosclerosis is a chronic inflammatory disease that is one of the leading risk factors for cardiovascular and/or cerebrovascular diseases [23] . Moreover, a growing body of recent data has shown that circulating miRs could influence the development and progression of vascular diseases, including atherosclerosis [24, 25] . Although atherosclerosis is common in clinical practice, the mechanisms of its genesis have 
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Cellular Physiology and Biochemistry not been fully elucidated. A previous study revealed that miR-29c was closely associated with atherosclerosis through several different mechanisms [26] . We found that miR-29c levels were higher in patients with increased CIMT than in those with normal CIMT values. At the same time, vascular inflammation in atheroprone vessels propagates throughout the arterial tree in dyslipidemic patients, thereby accelerating atherosclerotic progression [27] . CRP is one of the most commonly used biomarkers for inflammation in clinical practices. Several studies have shown that CRP is a potent risk factor that can independently predict future cardiovascular events, and is closely associated with an increased risk of target organ damage, such as atherosclerosis [28] . In this study, we also demonstrated that CRP levels were positively correlated with CIMT, which has been recommended for measuring cardiovascular and cerebrovascular risk in the general population. Inflammatory responses are an important aspect of atherosclerosis. We found that miR-29c levels were significantly correlated with the key inflammatory factor CRP. The phenotypic transformation and dysfunction of vascular smooth muscle cells, endothelial cells, and macrophages, such as abnormal proliferation and apoptosis, are a key pathological basis of atherosclerosis [29] . Previous studies have demonstrated that miR-29 regulates atherosclerosis by modulating miRNA targets that encode extracellular matrix proteins (e.g., collagen A and collagen 3A) [26] . Additionally, miR-29c could inhibit endotheliocyte migration and angiogenesis of human endothelial cells by suppressing the insulin like growth factor 1 [30] . Khorram O et al. also found that miR-29 played vital roles in atherosclerosis by regulating the expression of extracellular matrix [31] . These preclinical studies indicated that miR-29c could play several distinct roles during atherosclerosis development; thus, they provide underlying molecular mechanisms for our results.
This study had a few limitations. First, we evaluated miR-29c and CRP levels only from cross-sectional participants, we did not evaluate these during the prospective follow-up period, so we cannot draw causal conclusions about miR-29c directly leading to atherosclerosis. Second, we only used the inflammatory factor CRP to evaluate inflammatory conditions. Third, the number of study subjects was relatively small, and multicenter, prospective studies with larger sample sizes are needed to confirm our results. In addition, potential mechanisms linking miR-29c and CIMT were not elucidated, and this will require more preclinical studies in the future. Finally, we studied only miR-29c in our research. But many previous basic studies from references indicated that miR-29c may play an important role in the development of atherosclerosis through many mechanisms [14, 30, 31] . Therefore, those basic researches mentioned in the previous literatures provided a certain theoretical guarantee for our conclusion.
Conclusion
All in all, increased plasma miR-29c levels were independently associated with CIMT in a community population. Plasma miR-29c levels were closely associated with the inflammatory marker, CRP, which indicated that miR-29c may play an important role in atherosclerosis development. Thus, this novel marker may be useful for predicting the development of subclinical atherosclerosis or atherosclerosis and may further contribute to risk stratification.
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